Speaker(s): 

Mitch Onken, MD, at Geisinger - has nothing to disclose.

Mentor - Anthony Noto. MD 

Learning Objectives

• Determine management of asymptomatic carotid stenosis
• Identifying a population who will benefit from this
• Determine ideal surgical management (stenting vs endarterectomy)

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD, David Ermak, DO, Lisa Wasko, BSN, RN, SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

1. Please see my follow up questions below: 
   1. When is it appropriate to intervene on asymptomatic carotid stenosis (what degree of stenosis)?
   2. What patients will benefit from surgical intervention?
   3. What modality of surgical intervention is appropriate (CEA vs stenting)?